Ocrelizumab (Q2013780)

From Wikidata
Jump to: navigation, search
anti-CD20 monoclonal antibody under development for treatment of B cell leukemia and multiple sklerosis
  • 2H7
  • R-1594
  • RG-1594
  • PR-070769
edit
Language Label Description Also known as
English
Ocrelizumab
anti-CD20 monoclonal antibody under development for treatment of B cell leukemia and multiple sklerosis
  • 2H7
  • R-1594
  • RG-1594
  • PR-070769

Statements

A10SJL62JY
0 references
0 references
CHEMBL2108041
1 reference
edit
    edit
      edit
        edit
          edit
            edit